FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule

Up | Next | Most Recent

2004N-0559: OVERALL BENEFIT TO RISK CONSIDERATIONS FOR COX-2 SELECTIVE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND RELATED AGENTS
Document # Received Date Filed Date Submitter Code Submitter FR Date FR Page Comment Date Files Remarks
 
C1 12/27/2004 12/20/2004 Individual Consumer M. Rose          
NM1   01/18/2005 FDA FDA 01/19/2005 3044-3045 02/04/2005 pdf  
Signature: HUBBARD, WILLIAM
EC1 01/21/2005 01/20/2005 Individual Consumer M Lavin          
EC2 01/21/2005 01/21/2005 Individual Consumer R Ylitalo          
EC3 01/22/2005 01/22/2005 Health Professional K Gillam          
EC4 01/24/2005 01/23/2005 Individual Consumer S Ridner          
EC5 01/25/2005 01/24/2005 Individual Consumer R Nichols          
EC6 01/25/2005 01/24/2005 Individual Consumer B Geoffroy          
EC7 01/25/2005 01/24/2005 Individual Consumer J Johnson          
EC8 01/25/2005 01/24/2005 Individual Consumer none          
EC9 01/25/2005 01/24/2005 Health Professional Dr. V Conti          
EC10 01/25/2005 01/25/2005 Individual Consumer None          
EC11 01/25/2005 01/25/2005 Individual Consumer P Reliford          
EC12 01/25/2005 01/25/2005 Individual Consumer G Salles          
EC13 01/25/2005 01/25/2005 Individual Consumer D May          
EC14 01/26/2005 01/25/2005 Individual Consumer Dr. Wilson          
EC15 01/26/2005 01/25/2005 Individual Consumer C Merkel          
EC16 01/26/2005 01/25/2005 Individual Consumer K King          
EC17 01/26/2005 01/25/2005 Health Professional Medical Transcriptionist          

Top | Up | Next | Most Recent

Page last updated May 5, 2005 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management